Influence of antioxidants on the blood-brain barrier permeability during epileptic seizures

J Neurosci Res. 2001 Nov 15;66(4):674-8. doi: 10.1002/jnr.10023.

Abstract

Pentylenetetrazol-induced seizures in rats lead to the breakdown of the blood-brain barrier. We compared the disruption of the blood-brain barrier during epileptic seizure in untreated rats and in rats treated with vitamin E or selenium. The rats were supplemented with nontoxic doses of sodium selenite (4 pp) in drinking water for 3 months, or vitamin E (70 mg/kg) was given intraperitoneally for 30 min before the pentylenetetrazole injection. Evans-blue was used as a blood-brain barrier tracer and was given intravenously at a dose of 4 ml/kg of a 2% solution. The rats were divided into four experimental groups. Group I: control (n = 24); Group II: pentylenetetrazole-induced seizure (n = 12); Group III: vitamin E injected + seizure (n = 12); Group IV: Selenium supplemented + seizure (n = 12). The rats subjected to epileptic seizures showed Evans-blue albumin extravasations especially in the thalamic nuclei, brainstem, occipital, and frontal cortex. Mean values for Evans-blue dye were found to be 0.28 +/- 0.04 mg % brain tissue in control rats and 1.6 +/- 0.2 mg % brain tissue after epileptic seizures (P < 0.01). The magnitude of distribution of the blood-brain barrier during epileptic seizures was significantly less in rats treated with vitamin E or selenium. The mean value for Evans-blue dye was found to be 1.2 +/- 0.1 mg % brain tissue in selenium supplemented rats and 1.2 +/- 0.1 mg % brain tissue in vitamin E injected rats after epileptic seizures. This difference between treated and untreated animals was found to be significant (P < 0.05). The findings of the present study suggest that free radicals contribute to disruption of the blood-brain barrier during pentylenetetrazol-induced seizures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albumins / pharmacokinetics
  • Animals
  • Antioxidants / pharmacology*
  • Blood-Brain Barrier / drug effects*
  • Blood-Brain Barrier / physiology
  • Brain / drug effects
  • Brain / metabolism
  • Brain / physiopathology
  • Coloring Agents / pharmacokinetics
  • Convulsants / pharmacology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Epilepsy / drug therapy*
  • Epilepsy / metabolism
  • Epilepsy / physiopathology
  • Evans Blue / pharmacokinetics
  • Extravasation of Diagnostic and Therapeutic Materials / drug therapy
  • Extravasation of Diagnostic and Therapeutic Materials / metabolism
  • Extravasation of Diagnostic and Therapeutic Materials / physiopathology
  • Female
  • Free Radicals / antagonists & inhibitors
  • Free Radicals / metabolism
  • Neuroprotective Agents / pharmacology*
  • Pentylenetetrazole / pharmacology
  • Rats
  • Rats, Wistar
  • Selenium / pharmacology*
  • Vitamin E / pharmacology*

Substances

  • Albumins
  • Antioxidants
  • Coloring Agents
  • Convulsants
  • Free Radicals
  • Neuroprotective Agents
  • Vitamin E
  • Evans Blue
  • Selenium
  • Pentylenetetrazole